TREATMENT PHARMA ApS — Credit Rating and Financial Key Figures

TREATMENT PHARMA ApS (CVR number: 37208035) is a company from HORSENS. The company recorded a gross profit of -36.9 kDKK in 2024. The operating profit was -36.9 kDKK, while net earnings were -38.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -14 %, which can be considered poor and Return on Equity (ROE) was -49.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 22.8 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. TREATMENT PHARMA ApS's liquidity measured by quick ratio was 1.1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.